Highlighting relationships between heterogeneous biological data through graphical displays based on regularized canonical correlation analysis
暂无分享,去创建一个
Philippe Besse | Alain Baccini | Sébastien Déjean | Ignacio González | Pascal G.P. Martin | Olivier Gonçalves | Philippe C. Besse | S. Déjean | A. Baccini | I. González | Olivier Gonçalves | Pascal G. P. Martin
[1] Danh V. Nguyen,et al. Tumor classification by partial least squares using microarray gene expression data , 2002, Bioinform..
[2] C. Barbacioru,et al. Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1 , 2005, The Pharmacogenomics Journal.
[3] Guy Perrière,et al. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis , 2003, BMC Bioinformatics.
[4] S. Geer,et al. Regularization in statistics , 2006 .
[5] D. Jump,et al. Fatty acid regulation of hepatic gene transcription. , 2005, The Journal of nutrition.
[6] J. Byrd,et al. Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1 , 2005, Journal of Pharmacology and Experimental Therapeutics.
[7] C. Braak,et al. Interpreting canonical correlation analysis through biplots of structure correlations and weights , 1990 .
[8] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.
[9] G. Parmigiani,et al. The Analysis of Gene Expression Data , 2003 .
[10] H. Zou,et al. Regularization and variable selection via the elastic net , 2005 .
[11] J. Friedman,et al. A Statistical View of Some Chemometrics Regression Tools , 1993 .
[12] K. Ueda,et al. Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate , 2007, Bioscience, biotechnology, and biochemistry.
[13] D. Ma,et al. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids. , 2007, Oncology reports.
[14] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] Zhe-Sheng Chen,et al. MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenine* , 2003, Journal of Biological Chemistry.
[16] M. Delaforge,et al. Characterization of two pharmacophores on the multidrug transporter P-glycoprotein. , 2002, Molecular pharmacology.
[17] K. Paull,et al. P-glycoprotein substrates and antagonists cluster into two distinct groups. , 1997, Molecular pharmacology.
[18] Trevor Hastie,et al. Regularized linear discriminant analysis and its application in microarrays. , 2007, Biostatistics.
[19] J. Friedman. Regularized Discriminant Analysis , 1989 .
[20] R. Arceci,et al. P-glycoprotein mediates profound resistance to bisantrene. , 1994, Oncology research.
[21] Pietro Liò,et al. MotifScorer: using a compendium of microarrays to identify regulatory motifs , 2007, Bioinform..
[22] R. Tibshirani,et al. Penalized Discriminant Analysis , 1995 .
[23] J. Schneider,et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.
[24] M. Grever,et al. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. , 1994, Molecular pharmacology.
[25] Alain Baccini,et al. Stratégies pour l'analyse statistique de données transcriptomiques , 2005 .
[26] William R Sellers,et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. , 2003, Cancer cell.